The nation of Zimbabwe has declined a significant US health deal worth 367 million US dollars (272 million pounds) spanning five years because of the United States' insistence on confidential information.
This rejection came to light after a internal memorandum from December was leaked, which showed President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official spokesperson later explained that the United States was requesting health data for scientific study and profit but was not willing to guarantee the resulting advantages from any future vaccines.
"We must now begin the challenging and unfortunate process of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had furnished more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has urged continued negotiations to secure a deal agreeable to all parties so the nation's vital HIV treatment initiative can proceed.
Broader Context
This development comes after a comparable situation in neighbouring Kenya, where a high court halted a related deal with the US after concerns were raised about the safety of citizens' medical information.
Since returning to the presidency recently, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its expenditure was "inefficient" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
Based on statements, 16 nations in Africa have so far signed similar health pacts, representing more than $18.3bn in new funding.
Details of the Rejected Agreement
The money for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership could have provided significant advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on antiretroviral therapy through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that could result from that provided information," he stated.
"In essence, our country would provide the basic resources for scientific discovery with no assurance that the end products would be accessible to our people should a future pandemic arise."
Sovereignty and Global Health
He also said that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting frameworks already set up via the international organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing scheme designed to manage future global health emergencies.
"This mechanism is intended to guarantee that when a country provides its information, the benefits – including medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We welcome further discussions with our American counterparts on how future co-operation could be structured in a manner that respects the sovereignty and interests of both nations."
Medical Community Response
A leading public health body said it acknowledged the government's concerns, but urged that talks need to persist since a large portion of the country's HIV programmes depended on external financing.
"In cases where technical issues exist, including those relating to data governance or implementation frameworks, these can often be resolved through detailed discussion and mutually agreed protections," it added.
This impasse emphasises the ongoing challenges between receiving vital international aid and protecting a country's data in an increasingly interconnected world.